Effect of 6 Weeks of n-3 fatty-acid supplementation on oxidative stress in Judo athletes.
The aim of this investigation was to assess the effects of 6 wk of eicosapentanoic acid (EPA) and docosahexanoic acid (DHA) supplementation on resting and exercise-induced lipid peroxidation and antioxidant status in judoists. Subjects were randomly assigned to receive a placebo or a capsule of polyunsaturated fatty acids (PUFAs; 600 mg EPA and 400 mg DHA). Blood samples were collected in preexercise and postexercise conditions (judo-training session), both before and after the supplementation period. The following parameters were analyzed: α-tocopherol, retinol, lag phase , maximum rate of oxidation (Rmax) during the propagating chain reaction, maximum amount of conjugated dienes (CDmax) accumulated after the propagation phase, nitric oxide (NO) and malondyaldehide (MDA) concentrations, salivary glutathione peroxidase activity, and the lipid profile. Dietary data were collected using a 7-day dietary record. A significant interaction effect between supplementation and time (p < .01) on triglycerides was noted, with values significantly lower in the n-3 long-chain-PUFA (LCPUFA) group after supplementation than in the placebo group. Significant interaction effects between supplementation and time on resting MDA concentrations and Rmax were found (p = .03 and p = .04, respectively), with elevated values in the n-3 LCPUFA group after supplementation and no change in the placebo group's levels. The authors observed a significantly greater NO and oxidative-stress increase with exercise (MDA, Rmax, CDmax, and NO) in the n-3 LCPUFA group than with placebo. No main or interaction effects were found for retinol and α-tocopherol. These results indicate that supplementation with n-3 LCPUFAs significantly increased oxidative stress at rest and after a judo-training session.
Unité de Formation en Sciences et Techniques des Activités Physiques et Sportives, Orleans, France.
Edith
E
Filaire
Alain
A
Massart
Hugues
H
Portier
Matthieu
M
Rouveix
Fatima
F
Rosado
Anne S
AS
Bage
Mylene
M
Gobert
Denys
D
Durand
D000328:Adult; D000975:Antioxidants / Q000378:metabolism; D056352:Athletes; D015930:Diet Records; D019587:Dietary Supplements; D004281:Docosahexaenoic Acids / Q000008:administration & dosage / Q000097:blood / Q000494:pharmacology; D004311:Double-Blind Method; D015118:Eicosapentaenoic Acid / Q000008:administration & dosage / Q000097:blood / Q000494:pharmacology; D015525:Fatty Acids, Omega-3 / Q000008:administration & dosage / Q000097:blood / Q000494:pharmacology*; D005979:Glutathione Peroxidase / Q000187:drug effects / Q000378:metabolism; D006801:Humans; D015227:Lipid Peroxidation; D008297:Male; D008315:Malondialdehyde / Q000097:blood; D016139:Martial Arts; D018977:Micronutrients / Q000008:administration & dosage; D009569:Nitric Oxide / Q000097:blood; D018384:Oxidative Stress / Q000187:drug effects*; D012146:Rest; D014280:Triglycerides / Q000097:blood; D014801:Vitamin A / Q000097:blood; D055815:Young Adult; D024502:alpha-Tocopherol / Q000097:blood
D000975:Antioxidants; D015525:Fatty Acids, Omega-3; D018977:Micronutrients; D014280:Triglycerides; D014801:Vitamin A; D004281:Docosahexaenoic Acids; D009569:Nitric Oxide; D008315:Malondialdehyde; D015118:Eicosapentaenoic Acid; D005979:Glutathione Peroxidase; D024502:alpha-Tocopherol